Data / Drug companies / Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.: 28 products in the FDA NDC directory, labeler code 57884
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (labeler code 57884) lists 28 products in the FDA National Drug Code Directory, covering 2 finished drugs by generic name. By type: 23 bulk ingredients, 5 prescription drugs. Its main marketing category is bulk ingredients. The newest product started marketing on July 1, 2024.
The request: Watch Jiangsu Hengrui Pharmaceuticals Co., Ltd. (FDA labeler code 57884): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 57884
- Products in commercial distribution
- 28
- Packages
- 28
- Finished drugs by generic name
- 2
- Prescription products
- 5
- Over the counter products
- 0
- Flagged as original packager
- 5 of 5 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- May 21, 2007
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 23 | 82.1% |
| Generic drugs (ANDA) | 5 | 17.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 23 | 82.1% |
| Prescription drugs | 5 | 17.9% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Docetaxel | 3 | 21 |
| Bupivacaine | 2 | 2 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 21 | 75% |
| Injection, solution, concentrate | 3 | 10.7% |
| Injection, suspension, liposomal | 2 | 7.1% |
| Liquid | 2 | 7.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Microtubule Inhibitor | 3 |
| Amide Local Anesthetic | 2 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Bupivacaine | 57884-3252 | Injection, suspension, liposomal | Generic drugs (ANDA) | July 1, 2024 |
| Bupivacaine | 57884-3251 | Injection, suspension, liposomal | Generic drugs (ANDA) | July 1, 2024 |
| Bupivacaine | 57884-0038 | Powder | Bulk ingredients | June 29, 2020 |
| Gadobutrol | 57884-0035 | Powder | Bulk ingredients | May 28, 2020 |
| Gadoterate meglumine | 57884-0037 | Powder | Bulk ingredients | March 31, 2020 |
| Ioversol | 57884-0015 | Powder | Bulk ingredients | September 30, 2019 |
| Trabectedin | 57884-0033 | Powder | Bulk ingredients | May 10, 2019 |
| Ivabradine monosulfate | 57884-0031 | Powder | Bulk ingredients | February 7, 2018 |
| Carmustine | 57884-0032 | Powder | Bulk ingredients | November 20, 2017 |
| Docetaxel | 57884-3043 | Injection, solution, concentrate | Generic drugs (ANDA) | August 9, 2017 |
| Docetaxel | 57884-3042 | Injection, solution, concentrate | Generic drugs (ANDA) | August 9, 2017 |
| Docetaxel | 57884-3041 | Injection, solution, concentrate | Generic drugs (ANDA) | August 9, 2017 |
| Iodixanol | 57884-0029 | Powder | Bulk ingredients | January 11, 2017 |
| Sevoflurane | 57884-0036 | Liquid | Bulk ingredients | September 28, 2016 |
| Caspofungin acetate | 57884-0030 | Powder | Bulk ingredients | November 20, 2014 |
| Desflurane | 57884-0028 | Liquid | Bulk ingredients | September 22, 2014 |
| Tolvaptan | 57884-0027 | Powder | Bulk ingredients | January 6, 2014 |
| Fondaparinux sodium | 57884-0026 | Powder | Bulk ingredients | September 26, 2013 |
| Dexmedetomidine hydrochloride | 57884-0024 | Powder | Bulk ingredients | September 4, 2012 |
| Cyclophosphamide | 57884-0022 | Powder | Bulk ingredients | May 11, 2012 |
| Letrozole | 57884-0011 | Powder | Bulk ingredients | May 7, 2012 |
| Cisatracurium besylate | 57884-0018 | Powder | Bulk ingredients | November 17, 2011 |
| Docetaxel trihydrate | 57884-0014 | Powder | Bulk ingredients | September 13, 2010 |
| Etoposide | 57884-0008 | Powder | Bulk ingredients | August 25, 2010 |
| Ifosfamide | 57884-0006 | Powder | Bulk ingredients | August 25, 2010 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.